Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (1013) Gelnique (oxybutynin chloride), Watson Pharmaceuticals,
...Status: Approved January 2009 Treatment Area: overactive bladder General Information Gelnique (oxybutynin chloride) is an antispasmodic, antimuscarinic agent. It acts as a competitive antagonist of acetylcholine at postganglionic muscarinic receptors, resulting ...
...reactions • upper respiratory tract infections • dizziness • nasopharyngitis Mechanism of Action Gelnique (oxybutynin chloride) is an antispasmodic, antimuscarinic agent. It acts as a competitive antagonist of acetylcholine at postganglionic muscarinic receptors, resulting ...
View Page

2.  Newly Approved Drug Therapies (862) Sanctura (trospium chloride), Indevus Pharmaceuticals,
...May, 2004 Treatment Area: Overactive bladder General Information Sanctura oral tablets contain trospium, an antimuscarinic antispasmodic agent. Antimuscarinic agents act as parasympathetolytics in muscular tissues, and has been shown to reduce ...
View Page

3.  Study Posting (77) Trial #131448, Ulcerative Colitis, New Hyde Park, NY
...non-steroidal anti- inflammatory drugs within 7 days • Has undergone treatment with antidiarrheals and/or antispasmodics within 3 days • Are pregnant, breastfeeding, or intend to become pregnant during the study • Have ...
View Page

4.  Newly Approved Drug Therapies (822) Oxytrol (oxybutynin transdermal system), Watson Pharmaceuticals,
...Application site pruritus • Application site erythema • Application site vesicles Mechanism of Action Oxybutynin is an antispasmodic, anticholinergic agent. The active ingredient is dissolved in the thin layer of adhesive that sticks ...
View Page

5.  Study Posting (4036) Trial #94714, Bladder Disorders, Hollywood, FL
...study • Treatment with drugs known to affect mainly the urinary bladder function (e.g. anticholinergics, antispasmodics, serotonin-noradrenalin-reuptake-inhibitors) 14 days prior to Visit 2 and at any time during ...
View Page